This study investigates the diagnostic accuracy of a new PET/CT imaging technique for cancers in the pancreas, stomach, bile ducts, and ovaries. The purpose of this study is to explore how well this method can identify these cancers in their primary stages.
The focus is on evaluating the effectiveness of a novel radiotracer, FAPI, in detecting tumors with high stromal content. This study evaluates whether this imaging approach can enhance the detection of malignancies in these specific types of cancer.
- Who can participate: Adults scheduled for surgery to remove pancreatic, biliary, or gastric lesions, or early-stage epithelial ovarian cancer may participate. Participants must be over 18 years old and have signed informed consent.
- Study details: Participants will undergo PET/CT imaging using the investigational tracer FAPI. The study will assess how accurately this method can diagnose cancer. A placebo is not involved in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand